Clindamycin Phosphate and Benzoyl Peroxide Market Size, Share, Growth, Trends, Analysis and Forecast - 2028

The global clindamycin phosphate and benzoyl peroxide market is anticipated to grow at a significant CAGR during the forecast period (2022-2028).

According to National Center for Biotechnology Information, around 9.4% of the global population is affected by acne, which makes it the eighth most prevalent disease globally. The majority of affected people are teenagers due to hormonal changes throughout puberty are the root, while hereditary and other variables compound the problem.

Therefore it contributes to the growth of the clindamycin phosphate and benzoyl peroxide market across the globe. In order to reduce the acne bacteria, clindamycin phosphate and benzoyl peroxide products are used in the form of cream. For instance, Glenmark Pharmaceuticals Ltd. offers Alesa, Which is a lincosamide antibiotic. It is used to treat infections with anaerobic bacteria, however, can also be used to treat some protozoal diseases. Alesa is used for common topical treatment for acne and can be useful against some methicillin-resistant Staphylococcus aureus infections.

(Get 15% Discount on Buying this Report)
A full report of Global Clindamycin Phosphate and Benzoyl Peroxide Market is available at: https://orionmarketreports.com/clindamycin-phosphate-and-benzoyl-peroxide-market/94492/

Acne is a multifactorial skin disorder with a chronic, inflammatory etiology. Acne vulgaris, generally known as acne, is a widespread, chronic inflammatory condition of the sebaceous glands (sebaceous follicles). The skin develops inflamed elevations (papules, pustules, nodules, and cysts), comedones (blackheads and whiteheads), and scars as a result of this disease. Every person in their lifetime had acne, so the customer base is large, and the increase in the consumption of junk food (oily food) increases acne and thus, the market is anticipated to grow during the forecast period. According to the American Academy of Dermatology Association, approximately 85% of people between the ages of 12 and 24 experience at least minor acne.

Bausch Health Companies Inc. offers Acanya gel is used to treat the symptoms of Acne Vulgaris. Acanya belongs to a class of drugs called Acne Agents, Topical Combos. Acanya (clindamycin phosphate and benzoyl peroxide) Gel, 1.2%/2.5% is a combination product with two active ingredients in a white to off-white, opaque, smooth, aqueous gel formulation intended for topical use.

Clindamycin phosphate is a water-soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. All the products of clindamycin phosphate and benzoyl peroxide are available in hospital and drug store.

Some major players in the market include Bausch Health Companies Inc., Mylan NV., and Perrigo Co. plc, among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, Perrigo Co. plc offers Duac Gel, a clindamycin phosphate and benzoyl peroxide 1.2% / 5% topical gel, Duac Gel, 1.2%/5% is a fixed combination product with two active ingredients in a white to slightly yellow, opaque, aqueous gel formulation. Clindamycin phosphate is a water-soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin.

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

• Segment Covered-
o By Type
o By Distribution Channel

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Bausch Health Companies Inc., Mylan NV., and Perrigo Co. plc, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Clindamycin Phosphate and Benzoyl Peroxide Market Report by Segment

By Type
• 1.2%/2.5%
• 1.2%/3.75%
• 1%/5%
• 1%/3%

By Distribution Channel
• Hospital Pharmacies
• Drug Stores

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.